Patients successfully treated for a common heart rhythm disorder may no longer need blood thinners, a major study has found.

On November 3, 2025, Chief Technical Officer Joseph Shulman of Rhythm Pharmaceuticals ( RYTM +1.84%) exercised 9,748 options ...

"Rhythm forced to wait for Imcivree expansion as FDA delays decision " was originally created and published by Pharmaceutical ...

Investing.com -- Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) stock fell 3.4% in premarket trading Friday after the company announced the U.S. Food and Drug Administration (FDA) has extended its review ...

Rhythm Pharmaceuticals said on Friday the U.S. Food and Drug Administration has extended the review period for expanded ...

Company to hold conference today at 8:00 a.m. -- BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals said on Friday the U.S. Food and Drug Administration has extended the review period for expanded approval of its drug, Imcivree, as a treatment for a rare form of obesity.

Suri: The Seventh Note is an Indian-made rhythm action platformer coming to PS5 and PC. A release date hasn’t been announced ...

A mathematical model reveals circadian rhythms' impact on medication efficacy, particularly for neurological conditions like Parkinson’s disease and depression. The model focuses on dopamine reuptake ...

IMCIVREE now publicly covered for weight management due to Bardet-Biedl syndrome (BBS) in Ontario, Alberta, British Columbia, Saskatchewan, Nova Scotia and under NIHB ...

A hidden atrial dysfunction may raise stroke risk in people with transthyretin amyloid cardiomyopathy (ATTR-CM); however, a noninvasive assessment tool may help identify those at increased risk, ...

More than 4 in 5 women are gritting out menopause without seeking any treatment for their symptoms, researchers said in a new ...